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Background
HLA-B*7 supertype alleles are common among people of
African descent and are associated with viral control. In
particular, HLA-B*81 has been previously associated with
reduced viral fitness. We analyzed the immunodominance
of CD8+ T cell responses targeted by the B*7 supertype
alleles, viral evolution and fitness dynamics over 1yr in
acutely infected patients.
Methods
Six HLA-B*7 supertype participants [HLA-B*81 (n=2),
HLA-B*4201 (n=3) and HLA-B*4202 (n=1)] identified
with acute HIV-1 infection (antibody negative, vRNA posi-
tive) in KwaZulu-Natal, South Africa were studied. CD8+
T cell responses were measured by the IFN-g ELIspot
assay. Replication capacities of viruses encoding Gag-pro-
tease were measured. Full-length HIV-1 Gag clonal
sequencing of plasma was performed at ~14 days post
infection and 1yr later.
Results
The average viral set point of the 4 HLA-B*42 individuals
was higher than the 2 HLA-B*81, 4.89 vs 4.16 respectively.
Approximately 28 days after viral infection, CD8+ T cell
responses were directed to an average of 2/5 (range 2-4)
HLA-B*42 Gag-specific epitopes, median magnitude of
490 (range 170–2,480 SFC/million PBMCs). None of these
4 individuals had selected for escape mutations in the
immunodominant TL9 epitope at 1yr post-infection.
Interestingly, CD8+ T cell responses were only against the
TL9 epitope for the 2 HLA-B*81 patients with a median
magnitude of 950 (range 300–1780 SFC/million PBMCs).
One patient had a single wild type epitope in the trans-
mitted virus, compared to 4/5 wild type epitopes in the
second patient. However, CD8+ T cell responses were
only elicited at the TL9 epitope with a low magnitude
against T186S in the 1 patient with a much lower viral
fitness.
Conclusion
Strong, rather than broad immunodominant responses
in HLA-B*7 individuals is desirable in viral control.
Furthermore, this study emphasizes the advantage of
early dominant CD8+ T cell immune responses and an
attenuated virus in conferring clinical benefit among
HLA-B*7 supertype individuals.
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